Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5088172 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| Bromide SCHEMBL5088450 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| Bromide SCHEMBL5088644 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| Bromide SCHEMBL5084911 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| Bromide SCHEMBL1011285 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| Bromide SCHEMBL5087965 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| Bromide SCHEMBL5091658 | 1.00 | FDPS (0.42) | FDPSOPRM1SPHK1DNM1LMNA | |
| SCHEMBL414859 | 0.98 | FDPS (0.44) | FDPSOPRM1SPHK1DNM1LMNA | |
| SCHEMBL332946 | 0.98 | FDPS (0.44) | FDPSOPRM1SPHK1DNM1LMNA | |
| SCHEMBL29201295 | 0.98 | FDPS (0.44) | FDPSOPRM1SPHK1DNM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109678871-B | Method for preparing bisbenzylisoquinoline compounds | 山东师范大学 | 2020-09-29 | — | — | CN | claimed |
| CN-118804772-A | Catheter additives | 康沃特克有限公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-118804771-A | Intermittent catheter | 康沃特克有限公司 | 2024-10-18 | — | — | CN | disclosed |
| US-20240139078-A1 | DENTAL FILLING KIT | KURARAY NORITAKE DENTAL INC. (JP) | 2024-05-02 | — | — | US | disclosed |
| CN-117729948-A | Intermittent catheter | 康沃特克有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117729949-A | Intermittent catheter | 康沃特克有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117677410-A | Packaged intermittent catheter | 康沃特克有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117651572-A | Intermittent catheter | 康沃特克有限公司 | 2024-03-05 | — | — | CN | disclosed |
| EP-4324450-A1 | DENTAL FILLING KIT | Kuraray Noritake Dental Inc. (JP) | 2024-02-21 | — | — | EP | disclosed |
| CN-116981488-A | Intermittent catheter | 康沃特克有限公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2022220250-A1 | DENTAL FILLING KIT | クラレノリタケデンタル株式会社 | 2022-10-20 | — | — | WO | disclosed |
| CN-108017479-B | Method for producing aromatic compound | 东曹株式会社 | 2022-07-29 | — | — | CN | disclosed |
| CN-109678871-B | Method for preparing bisbenzylisoquinoline compounds | 山东师范大学 | 2020-09-29 | — | — | CN | disclosed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| US-20030064102-A1 | Antimicrobial Composition | NAKATSUKA KAZUMITSU (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-1285947-A1 | ANTIMICROBIAL COMPOSITION | KURARAY CO., LTD. (JP) | 2003-02-26 | — | — | EP | disclosed |
| EP-0271839-B1 | Casting polymerisation process for preparing sulfur-containing urethane resin lens | MITSUI TOATSU CHEMICALS (JP) | 1996-03-06 | — | — | EP | disclosed |
| EP-0271839-A2 | Casting polymerisation process for preparing sulfur-containing urethane resin lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1988-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139078-A1 | DENTAL FILLING KIT | DHX29, DHX35, DHX15 | FDPS 2787/4885OPRM1 2641/4885SPHK1 4507/4885 |
| US-20030064102-A1 | Antimicrobial Composition | AAAS, H1-0, H1-10 | FDPS 4276/4885OPRM1 634/4885SPHK1 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.